Discontinued — last reported Q4 '25
Chevron Other Income (Expense) increased by 186.6% to $1.65B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 47.9%, from $3.17B to $1.65B. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a 2.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.00M | $511.00M | $2.34B | -$25.00M | $923.00M | $726.00M | $2.08B | $668.00M | $440.00M | $845.00M | -$1.82B | $924.00M | $401.00M | $482.00M | $3.17B | $534.00M | -$89.00M | $576.00M | $1.65B |
| QoQ Change | — | >999% | +356.9% | -101.1% | >999% | -21.3% | +186.9% | -67.9% | -34.1% | +92.0% | -315.3% | +150.8% | -56.6% | +20.2% | +557.3% | -83.1% | -116.7% | +747.2% | +186.6% |
| YoY Change | — | — | — | — | >999% | +42.1% | -10.8% | >999% | -52.3% | +16.4% | -187.3% | +38.3% | -8.9% | -43.0% | +274.2% | -42.2% | -122.2% | +19.5% | -47.9% |
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| All Other | — | — | — | $387.00M | -$207.00M | $263.00M | $106.00M | $115.00M |
| Reportable Segment, Aggregation before Other Operating Segment | -$319.25M | -$319.25M | $514.00M | — | — | — | — | — |
| Total | $845.00M | -$1.82B | $924.00M | $534.00M | -$89.00M | $576.00M | $1.65B | — |
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Int’l. | — | — | — | — | — | -$168.00M | $129.00M | $141.00M |
| International | $203.75M | $203.75M | $203.75M | $361.00M | $227.00M | — | — | — |
| Total | $440.00M | $845.00M | -$1.82B | $924.00M | $534.00M | -$89.00M | $576.00M | — |
International was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.